Tirzepatide Reduced Albuminuria in T2D Patients With Heart Risk Subanalysis of SURPASS-4 trial compared the GLP-1/GIP agonist against insulin glargine Jun 06, 2022
Is Diabetes a Risk Factor for Long COVID? Possibly. Mixed results in seven-study scoping review Jun 05, 2022
Dulaglutide Improves HbA1c for Youth With Type 2 Diabetes Safety profile consistent with that reported in adults Jun 05, 2022
Tirzepatide Serves Up Major Weight-Loss Win in Patients With Obesity SURMOUNT-1 trial tested GIP/GLP-1 receptor agonist in people without diabetes Jun 05, 2022
Bariatric Surgery Cuts Cancer Incidence, Death Risk Study looked at people with obesity who underwent two most popular procedures Jun 03, 2022
CDC Study: Income-Related Inequalities Widening in Diabetes Disparities differed by sex and age group Jul 01, 2021
ADA 2021 Roundup: SoliMix Trial; Byetta for Teens; Driving in Hypoglycemia Noteworthy research from the American Diabetes Association virtual meeting Jun 30, 2021
Genetics, Socioeconomic Factors Each Tied to Diabetes and Obesity People with highest risk genetics more than 15 times more likely to have T2D Jun 30, 2021
Liraglutide and Insulin Come Out on Top for Glycemic Control in GRADE study Head-to-head comparison could help individualize treatment Jun 29, 2021
COVID-19 Pandemic Upped Anxiety in Adults, Kids With Diabetes Providers should be screening patients on how COVID is affecting them, says researcher Jun 29, 2021
Investigational GLP-1 RA Cuts Heart, Renal Risk in Vulnerable Diabetes Patients Exendin-4-based drug succeeded in cardiovascular outcomes trial Jun 28, 2021
180-Day Continuous Glucose Monitor Shows Promise in Adults With Diabetes Implantable Eversense system demonstrates accuracy in prospective study Jun 28, 2021
Hospitalization Rates for New-Onset Type 2 Diabetes in Kids Took Off During Pandemic "COVID-19 disrupted our lives in more ways than we realize" Jun 26, 2021
Combo GIP/GLP-1 Drug Superior for HbA1c Reduction in T2D 40-week trial compared tirzepatide head-to-head with injectable semaglutide Jun 25, 2021
Ertugliflozin Tx: Safe for the Heart in Patients With T2D Phase III VERTIS-CV trial meets primary endpoint of MACE non-inferiority Jun 17, 2020
No Added CV Risk for Oral Semaglutide in T2D Safety study buffs resume for oral GLP-1 receptor agonist Jun 11, 2019
Urine Marker Predicts Kidney Benefit With Trulicity Secondary AWARD-7 analysis finds subgroup getting the most renal protection Jun 11, 2019
Dapagliflozin Boosts Renal Function in T2D Secondary outcomes build on previously reported cardiovascular benefit from SGLT2 inhibitors Jun 10, 2019
Another GLP-1 Agent Cuts Heart Risk in T2D Dulaglutide added to the growing list of diabetes treatments to show added benefit Jun 10, 2019
Novel Anti-CD3 Antibody Delays Progression to T1D Single course of teplizumab slowed march to clinical type 1 diabetes in high-risk people Jun 09, 2019
Expert Panel Defines CGM Time-in-Range Targets Seventy percent of readings should stay between 70-180 mg/dL, according to recommendations Jun 09, 2019
Vitamin D Flops for Diabetes Prevention Highly anticipated trial finds no significant difference compared to placebo after nearly three years follow-up Jun 07, 2019
SGLT-2 Inhibitors Tied to Lower All-Cause Mortality Risk Head-to-head comparison with DPP-4 inhibitors also showed heart protection Jun 26, 2018
Incretin/SGLT-2 Combo Efficacy Persists 2 Years Exenatide plus dapagliflozin maintained biomarker benefits in long-term study Jun 26, 2018
'Artificial Pancreas' System Boosts In-Hospital T2D Control Less time out of range, no increase in insulin or lows with fully-automated system Jun 25, 2018
Early T2D Treatment in Youth Disappoints Metformin, insulin didn't stop deterioration of beta-cells in adolescents with impaired glucose Jun 25, 2018
TB Vaccine for T1D Study Stirs Controversy Long-term data suggest BCG vaccine may alter immune attack Jun 25, 2018
Intensive Treatment Doesn't Cost More Therapy aimed at treating all organ targets extends life Jun 25, 2018
Farxiga Lowers HbA1c in Type 1 Diabetes Weight loss also accompanied better glycemic control Jun 25, 2018
Eversense CGM Comes Out on Top for Accuracy in T1D Dexcom G5 performed best in hypoglycemia Jun 25, 2018
Sotagliflozin Tx Tied to HbA1c Reductions in T1D But instances of diabetic ketoacidosis are a concern, expert says Jun 24, 2018
GLP-1 Drug Boosts T1D Control A1c, glucose, weight, blood pressure all improved in randomized trial Jun 24, 2018
No Greater Amputation Risk with Canagliflozin in T2D Patients Real-world analysis done in over 100,000 canagliflozin users Jun 24, 2018
Basal Insulin Doesn't Cut Hypoglycemia Risk Vs NPH in T2D Similar hypoglycemia-related emergency department and hospital admissions Jun 24, 2018
Dual-Hormone Artificial Pancreas Ups T1D Glucose Control Rapid insulin plus pramlintide also reduced glucose variability Jun 24, 2018
180-Day Implantable CGM Deemed Safe in T1D Patients The system's accuracy stabilized with longer use, researchers reported Jun 23, 2018
Closed-Loop T1D Systems Show Promise Omnipod, Diabeloop systems offer better glucose control than conventional treatment Jun 23, 2018
Severity of Mom's Diabetes May Up Autism Risk in Their Kids But GDM diagnosed after 26 weeks' gestation not associated with excess risk versus no diabetes Jun 23, 2018
ADA's 2018 Meeting Spotlight Latest Trials One of anticipated includes pediatric outcomes of RISE trial Jun 21, 2018
Nasal Glucagon Helps Hypoglycemia in Adults with T1D Possible alternative to injectable recombinant glucagon Jun 14, 2017